Labshake search
Citations for Tocris :
1 - 50 of 54 citations for IGF I Rat since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... GF 109203X (Bisindoylmaleimide I, BIM I) and AIM-100 were from Tocris-Cookson ...
-
bioRxiv - Cancer Biology 2020Quote: ... 0.01µM Gastrin I (TOCRIS 3006), 0.1µg/mL Noggin (Peprotech 250-38) ...
-
bioRxiv - Physiology 2023Quote: ... an [Ca2+]i chelator (Tocris); NiCl2 hexahydrate ...
-
bioRxiv - Cell Biology 2024Quote: ... 0.25μM Sant-I (Tocris-#1974), 2μM Retinoic Acid (Sigma-#R2625) ...
-
Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumorsbioRxiv - Cancer Biology 2020Quote: ... 0.01 μM Gastrin I (TOCRIS 3006), 0.1 μg/mL Noggin (Peprotech 250-38) ...
-
bioRxiv - Neuroscience 2021Quote: ... [Pro3]-GIP (Rat) was purchased from Tocris, a Bio-Techne brand (Abingdon ...
-
bioRxiv - Cell Biology 2021Quote: ... a Rac1-inhibitor (Rac1-i; No2161, Tocris). To inhibit Dock release from Elmo ...
-
bioRxiv - Cancer Biology 2023Quote: ... hGastrin I 0.01μM (Tocris Bioscience, Cat# 3006), N-acetylcysteine 1.25mM (Sigma-Aldrich ...
-
bioRxiv - Developmental Biology 2020Quote: ... and TGFβ Receptor I Inhibitor II (25nM; Tocris were also used in this study ...
-
bioRxiv - Neuroscience 2019Quote: ... Rats received injections of NMDA (12.5 µg/µL; Tocris) in saline vehicle at a rate of 0.1 µL/min at the following locations relative to bregma ...
-
bioRxiv - Neuroscience 2021Quote: ... rats were infused with 0.5 μL of muscimol (Tocris) or physiological saline with a flow rate of 0.25 μL/min ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were treated with 330nM Torin I (# 4247, Tocris) for 1 hour ...
-
bioRxiv - Neuroscience 2023Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 µM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Cell Biology 2023Quote: ... Rats were treated daily with 1 nmol MC903 (Tocris Bioscience) on ears in the presence of 50 ug OVA (Sigma-Aldrich ...
-
bioRxiv - Physiology 2024Quote: ... injected with 2 mg/kg acylated rat ghrelin (1465, Tocris) solubilized in PBS using an injection volume of 2 mL/kg body weight ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris #I-440-01M) and mounted in modified rose chambers ...
-
bioRxiv - Neuroscience 2020Quote: ... or Eeyarestatin I (10 μM, TOCRIS, Bio-Techne GmbH, 3922). Both compounds were pre-diluted in DMSO (Sigma-Aldrich D2650) ...
-
bioRxiv - Bioengineering 2019Quote: ... TGF-β type I receptor inhibitor A83-01 500nM (Tocris), P38 inhibitor SB202190 10μM(Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2019Quote: ... rats were microinjection with either artificial cerebral spinal fluid (aCSF; Tocris) or 300 μM clozapine-N-oxide (CNO ...
-
bioRxiv - Neuroscience 2021Quote: ... at which point 50nM CRF (human/rat, Cat. No 1151, Tocris) was added to the bath ...
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 500 nM TGF-b type I receptor inhibitor A83-01 (Tocris), 10 µM P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.5 μM TGFb type I Receptor inhibitor A83-01 (Tocris #2939). In addition ...
-
bioRxiv - Cancer Biology 2023Quote: ... hGastrin I (final concentration, 0.01 μmol/L) (Tocris Bioscience, Bristol, UK), N-acetylcysteine (final concentration ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.5 μM TGF-b type I receptor inhibitor A83-01 (Tocris Bioscience) and 1μM PGE2 (Tocris Bioscience) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5000 nM TGF-b type I receptor inhibitor A83-01 (Tocris #2939), 10 nM Prostaglandin E2 (Tocris #2296) ...
-
bioRxiv - Developmental Biology 2021Quote: ... GANT61, a Gli1/2 inhibitor (Gli-I, #3191) was purchased from Tocris Bioscience (Bio-Techne ...
-
bioRxiv - Immunology 2020Quote: ... 1 mM PMSF) supplemented with protease inhibitors (Protease Inhibitor Cocktail I, Tocris). Homogenates were centrifuged at 5000 g for 15 min at 4°C and supernatants were collected.
-
bioRxiv - Molecular Biology 2022Quote: ... MED14 depletion was combined with treatment with I-BET 151 dihydrochloride (Tocris, 4650), a BET bromodomain inhibitor ...
-
bioRxiv - Developmental Biology 2021Quote: ... The following inhibitors were used: Jak2/Stat3 inhibitor (Cucurbitacin I, 100 nM, Tocris), Jak2 inhibitor (Fedratinib ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Cat# 4126, Tocris), 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2021Quote: ... OFC-lesioned rats received injections of NMDA (12.5 μg/μL in saline vehicle; Tocris) at the following locations (relative to bregma) ...
-
bioRxiv - Neuroscience 2022Quote: ... rats were bilaterally infused with either scopolamine (10 ug/side; Tocris Bioscience, Bristol, UK), a nonselective muscarinic receptor antagonist ...
-
bioRxiv - Neuroscience 2022Quote: ... rats were bilaterally infused with either mecamylamine (10 ug/side; Tocris Bioscience, Bristol, UK), a nonselective nicotinic receptor antagonist ...
-
bioRxiv - Neuroscience 2021Quote: Rats were intraperitoneally injected with 1 mg/kg scopolamine hydrobromide (Tocris Bioscience, category number 1414), dissolved in 0.9% NaCl solution ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were pre-treated for 6 hours with 100 μM CPYPP (DOCK-i; No4568, Tocris). To inhibit Shh signaling ...
-
bioRxiv - Developmental Biology 2022Quote: ... the base media is supplemented with 1uM of BMP-I inhibitor (LDN-193189) (Tocris, # 6053), 5uM of GSK3-Inhibitor (CHIR99021 ...
-
bioRxiv - Neuroscience 2021Quote: ... Slices were then moved to room temperature oxygenated ACSF supplemented with 50 nM of rat CGRP (Tocris) or vehicle and maintained in this solution for a minimum of 2h.
-
bioRxiv - Cell Biology 2024Quote: ... Day 6: The medium was changed with the differentiation medium containing 0.25μM Sant-I (Tocris-#1974), 100ng/mL Noggin (Sino Biological-#10267) ...
-
bioRxiv - Neuroscience 2022Quote: ... To monitor acute changes in [Cl-]i we bath applied GABAA receptor agonist muscimol (Tocris, 10 μM) and imaged at lower resolution (every 2 minutes at a resolution of 4.1 pixels/μm (512×512 pixels ...
-
bioRxiv - Neuroscience 2019Quote: ... (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester (K252a, 200 nM) (Tocris), 7,8-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one (DHF ...
-
bioRxiv - Neuroscience 2021Quote: ... Four of the rats were also infused with 2 μL of either physiological saline or 5 μg/μL yohimbine (Tocris) with a flow rate of 0.5 μL/min as previously reported (Caetano et al. ...
-
bioRxiv - Immunology 2019Quote: ... To test the effect of VIP on ILC3, cells were incubated with different concentrations of VIP (human, rat, mouse, rabbit, canine, porcine) from Tocris, Bay 55-9837 (Tocris) ...
-
bioRxiv - Molecular Biology 2023Quote: ... Male Sprague Dawley (SD) rats (6-10 weeks old) were administered with a single dose of Sugen 5416 (SU) (20mg/kg, Tocris) delivered in CMC vehicle (as previously described)16 or DMSO and placed in hypoxia chambers (10% O2 ...
-
bioRxiv - Neuroscience 2022Quote: ... LY 333531 (ruboxistaurin, 4738), sumanirole maleate (2773), GF 109203X (BIM I), and (RS)-3,5-dihydroxyphenylglycine (DHPG, 0342) were from Tocris. (S,S)-CE-158 was synthesized as previously described56 ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...